LEO PHARMA A/S: Financial statements 2021
CVR: 56759514
Source: annual report 2021, Danish Business Authority
01/01/2021 – 31/12/2021
LEO PHARMA A/S (CVR 56759514) has filed annual accounts for 2021. In 2021, the company reported revenue of DKK 9,957,000,000 and a net result of DKK -4,868,000,000 compared with DKK -951,000,000 the year before. That is a decrease of 1.7% compared with the year before. The profit margin was -48.9%. Equity in the 2021 report amounted to DKK 5,537,000,000. The solvency ratio was 23.4%.
- Revenue
- DKK 9,957,000,000
- Gross Profit
- DKK 5,995,000,000
- Profit/Loss
- DKK -4,868,000,000
- Equity
- DKK 5,537,000,000
- Total Assets
- DKK 23,695,000,000
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | 10 mia. | 6 mia. | -4.9 mia. | 5.5 mia. | - |
| 2020 | 10.1 mia. | 6.8 mia. | -951 mio. | 6.9 mia. | - |
| 2019 | 10.8 mia. | 7.5 mia. | -1.3 mia. | 8.1 mia. | - |
| 2018 | 10.4 mia. | 7.4 mia. | 1.3 mia. | 9.5 mia. | - |
| 2017 | 10.5 mia. | 7.5 mia. | 1.4 mia. | 8.3 mia. | - |
Official annual report
Find more companies like LEO PHARMA A/S
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
As of November 30, 2021, Anders Kronborg is registered as adm. dir. of LEO PHARMA A/S.
As of November 30, 2021, Catherine Thérése Jeanne Mazzacco has stepped down as adm. dir. of LEO PHARMA A/S.
As of November 29, 2021, Anders Kronborg has stepped down as director of LEO PHARMA A/S.
As of September 13, 2021, Peter Helt Jacobsen Haahr has joined the board of directors of LEO PHARMA A/S.
As of August 1, 2021, Jesper Brandgaard has joined the board of directors of LEO PHARMA A/S.
As of August 1, 2021, Jesper Mailind has joined the board of directors of LEO PHARMA A/S.
As of August 1, 2021, Anders Ekblom has joined the board of directors of LEO PHARMA A/S.
As of July 31, 2021, Jesper Mailind has left the board of directors of LEO PHARMA A/S.
As of July 31, 2021, Anders Ekblom has left the board of directors of LEO PHARMA A/S.
As of July 21, 2021, Jonas Wilhelm Agnblad has joined the board of directors of LEO PHARMA A/S.
About LEO PHARMA A/S
LEO PHARMA A/S is a Danish company of the type Aktieselskab based in Ballerup, founded in 1962. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named LØVENS KEMISKE FABRIK PRODUKTIONSAKTIESELSKAB. The management consists of Christophe Dominique Luc Charles Bourdon and Philip Harald Eickhoff. The board consists of Jesper Brandgaard (chair), Paul Olivier Marie Navarre, Peter Helt Jacobsen Haahr and Aino Anna Liisa Hurme. The company is owned by LEO Holding A/S and Cidron Savanna 4 SARL. The company has 1,047 employees (2026). In 2025, the company reported revenue of DKK 13,499,000,000 and a net result of DKK 2,489,000,000 compared with DKK -1,776,000,000 the year before. Equity in the 2025 report amounted to DKK 5,262,000,000.